RevBio
Total Raised
$36.43MInvestors Count
11Funding, Valuation & Revenue
15 Fundings
RevBio has raised $36.43M over 15 rounds.
RevBio's latest funding round was a Grant - VII for $2.2M on October 6, 2025.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
10/6/2025 | Grant - VII | $2.2M | 4 | |||
9/16/2024 | Grant - VI | $2.4M | 2 | |||
10/25/2023 | Grant - V | $2M | 2 | |||
10/6/2023 | Grant - IV | |||||
6/7/2023 | Grant - III |
Date | 10/6/2025 | 9/16/2024 | 10/25/2023 | 10/6/2023 | 6/7/2023 |
|---|---|---|---|---|---|
Round | Grant - VII | Grant - VI | Grant - V | Grant - IV | Grant - III |
Amount | $2.2M | $2.4M | $2M | ||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 4 | 2 | 2 |
RevBio Investors
11 Investors
RevBio has 11 investors. National Institute on Aging invested in RevBio's Grant - VII funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
9/20/2022 | 10/6/2025 | 3 Grant - II, Grant - IV (2023), Grant - VII (2025) | Government | Maryland | ||
9/16/2024 | 9/16/2024 | 1 Grant - VI | Government | United States | ||
10/25/2023 | 10/25/2023 | 1 Grant - V | Government | Maryland | ||
Government | Maryland | |||||
Corporation | California |
First funding | 9/20/2022 | 9/16/2024 | 10/25/2023 | ||
|---|---|---|---|---|---|
Last Funding | 10/6/2025 | 9/16/2024 | 10/25/2023 | ||
Investor | |||||
Rounds | 3 Grant - II, Grant - IV (2023), Grant - VII (2025) | 1 Grant - VI | 1 Grant - V | ||
Board Seats | |||||
Type | Government | Government | Government | Government | Corporation |
Location | Maryland | United States | Maryland | Maryland | California |
Compare RevBio to Competitors
MicroQuin is a biotechnology company focused on the treatment of diseases and injuries by controlling the intracellular environment. The company develops therapeutics that intervene in cellular processes to rebalance the intracellular environment, with the goal of addressing disease and injury progression. MicroQuin's solutions are intended to support the body's response to infections, injuries, and various diseases at the cellular level. It was founded in 2016 and is based in San Francisco, California.
Space Bio Laboratories conducts research and development of regenerative medicine and medical devices in the healthcare sector. The company engages in cell therapy research, including cultivating cells under simulated microgravity conditions, and developing rehabilitation robotics to assist in recovery. Its offerings include the Gravite® device for creating simulated microgravity environments for cell culture and the RE-Gait® device for providing walking support in rehabilitation therapies. It was founded in 2005 and is based in Hiroshima, Japan.
Interstellar Lab develops biospheric systems for autonomous plant cultivation in terrestrial and extraterrestrial environments. The company provides platforms that automate the cultivation process by adjusting temperature, humidity, light, and nutrients to support plant growth with human intervention. Interstellar Lab's technology supports plant-based ingredient production for industries like health, beauty, and food & beverage, and has been noted by NASA for potential use in space. It was founded in 2018 and is based in Paris, France.
Gravitilab specializes in microgravity testing and space access within the aerospace industry. The company offers end-to-end testing services that provide extended time in microgravity environments for scientific research and space system validation, emphasizing cost-effectiveness and sustainability. Gravitilab primarily serves sectors that require microgravity conditions for research and development, including scientific institutions and space technology companies. It was founded in 2018 and is based in Norfolk, England.
Firefly Biotech focuses on the development of advanced technology for space healthcare and medical research. The company offers tools and approaches for microgravity simulation, advanced tissue culture consumables, space health diagnostics, and rapid prototyping for medical devices. Firefly Biotech primarily serves sectors involved in space research and biomedicine. It is based in Adelaide, South Australia.
Satelife focuses on AI-driven wildfire mitigation strategies in the risk assessment and insurance sectors. The company provides wildfire risk reduction plans based on satellite imagery and expert recommendations to help assess and mitigate wildfire risks for clients in the insurance industry. It was founded in 2023.
Loading...